Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
about
Use of 5-alpha-reductase inhibitors did not increase the risk of cardiovascular diseases in patients with benign prostate hyperplasia: a five-year follow-up study.Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment.5-alpha-reductase inhibitor therapy postpones urine retention and prostate surgery in patients with prostate enlargement and a maximum uroflow rate of less than 15 ml/sec.The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study.Silodosin: a review of its use in the treatment of the signs and symptoms of benign prostatic hyperplasia.A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia.Survey and Risk Factors for Lower Urinary Tract Storage Symptoms in Middle-Aged and Older Stroke Patients in Urban China.Flurbiprofen alone and in combination with alfuzosin for the management of lower urinary tract symptoms.5-alpha-reductase inhibitors and the risk of diabetes mellitus: A nationwide population-based study.Efficacy and safety of a fixed-dose combination of dutasteride and tamsulosin treatment (Duodart(®) ) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the manageEmerging drugs for the treatment of benign prostatic hyperplasia.2-Methoxyestradiol Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats through Inhibition of HIF-1/TGF-/Smad2 Axis
P2860
Q35213928-3C26A982-F3A2-428F-BABC-0AD9B85CC8A6Q35537838-BD8B9EFC-D6EA-45A5-8848-50ED4BA2FFBEQ36342157-1BD3CECA-1067-4BDE-B150-A924B4A38DBCQ36680616-9A9EA901-C957-4402-9305-3C6A48249FF5Q38313282-7318B217-83EB-43D7-ABA6-25016507C528Q38485721-7A6334E5-C7F2-4BB8-A928-38616E6E67FFQ39824341-D42CF1D7-4EDB-47F8-A36E-C70F6F32D9B7Q39921832-F5DB474F-BE88-41BE-831D-B4BDCA42BE51Q41338878-1048D268-B6DB-47AF-8623-571BD2AC2EA2Q43902268-442A1EDB-5F72-4E89-9D16-FF780F181D7EQ47553287-8487106C-B53C-44E6-ACE3-C7707AD885C8Q58805809-88B5DB2E-DAEC-44A2-BAAB-E76880B2FA19
P2860
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
@ast
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
@en
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
@nl
type
label
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
@ast
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
@en
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
@nl
prefLabel
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
@ast
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
@en
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
@nl
P1476
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
@en
P2093
Carlos Martins Silva
João Silva
P356
10.1097/MOU.0000000000000007
P577
2014-01-01T00:00:00Z